actos verdict 9 billion 250x140 Actos verdict illustrates companies that co promote drugs can be held liable for injuries, failure to warnA federal judge’s decision not to overturn a jury’s $9 billion verdict against Takeda Pharmaceutical Co. and Eli Lilly for withholding bladder cancer risks from doctors and patients sends a new warning to pharmaceutical companies that co-promote a drug. That they, too, can be held liable for failing to warn of a drug’s potential risks even if they are not responsible for updating the drug’s safety label.

Last month, Judge Doherty upheld a jury verdict awarding $3 billion in punitive damages against Eli Lilly and $6 billion in punitive damages against Takeda for withholding information that the Type 2 diabetes drug Actos could increase the risk of bladder cancer.

Eli Lilly had previously tried to skirt liability in the Actos bladder cancer lawsuit, claiming that it shouldn’t be held liable since its role was limited to sales and marketing functions. But U.S. District Judge Rebecca Doherty disagreed, saying that Eli Lilly was just as guilty as Takeda since the company was fully aware of Actos’ potential bladder cancer risks and its financial interest even after its co-promotion deal with Takeda ended in 2006.

Plaintiffs presented evidence that in 2003 Eli Lilly agreed not to bring up bladder cancer risks with Actos during its phone calls to doctors to promote the drug. Judge Doherty also noted that Eli Lilly worked with Takeda to develop a strategic plan to deal with bladder cancer concerns raised by federal regulators before Actos was approved for marketing.

Judge Doherty’s ruling upheld the jury’s decision to rule against the drugmakers. She will address the size of the verdict at a later date. The $9 billion judgment is considered to be the seventh largest punitive damages award in U.S. history.

Source: Law 360



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

$2.4 Billion Actos Bladder Cancer Settlement Explained

Beasley Allen principal Frank Woodson discusses the recent $2.4 billion Actos settlement on Ringler...
Takeda settles Actos bladder cancer lawsuits for $2.4 billion

$2.4 billion settlement agreement reached in Actos...

Takeda Pharmaceutical Co. has agreed to a $2.4 billion settlement to resolve bladder cancer claims tied...

Actos and its link to bladder cancer discussed by...

Actos, manufactured by Takeda Pharmaceuticals, was issued a warning by the FDA saying people who have...

Actos, TVM and Zohydro litigation discussed by Andy...

Beasley Allen attorneys Andy Birchfield and Leigh O'Dell discuss their progress on litigation involving...
Federal jury orders drugmakers to pay $9 billion for actos cancer risk

Federal jury orders drug makers Takeda, Eli Lilly to...

Jurors found Takeda Pharmaceutical Co. and Eli Lilly & Co. liable for a combined $9 billion in punitive...

Type 2 diabetes drugs may increase risk of pancreatic...

A commonly prescribed class of Type 2 diabetes drugs known as incretin mimetics may put users at risk...

A positive manner

Several years ago my brother and sister -in-law were in a terrible car accident. My sister in-law was paralyzed from her neck down. Beasley Allen handled the case for my brother to see to it that my sister-in-law received the proper and necessary care she needed. I appreciate the attorneys and staff of Beasley Allen in handling this matter quickly and in a positive manner. Good job Beasley Allen!!

—Joan